Jacqueline Elizabeth Shea serves as Chief Executive Officer of INOVIO PHARMACEUTICALS, INC. (INO). Shea has reported 7 insider filings with the SEC since 2025. The most recent filing was in May 2026.
Every role Jacqueline Elizabeth Shea has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
INOVIO PHARMACEUTICALS, INC. (INO)7 filingsUpdated Aug 31, 2026
Jacqueline Elizabeth Shea is Chief Executive Officer, Director of INOVIO PHARMACEUTICALS, INC. (INO). 7 SEC Form 4 filings on record going back to 2025, most recently on 21 May 2026.
Every recent SEC Form 4 transaction Jacqueline Elizabeth Shea has reported, most recent first.
InsiderAlpha's records for Jacqueline Elizabeth Shea go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
No other insider has filed at Jacqueline Elizabeth Shea's companies, so these are insiders reporting open-market trades at other companies in the same sector.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Jacqueline Elizabeth Shea is a corporate insider, tracked as Chief Executive Officer, Director of INOVIO PHARMACEUTICALS, INC. (INO). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 21 May 2026, one of 7 filings going back to 2025.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$INO INOVIO PHARMACEUTICALS, INC.7.7K shares @ $1.30$10K